Sign Out
Malignant Pleural Mesothelioma: Pemetrexed Kabi in combination with cisplatin is indicated for the treatment of chemotherapy naïve patients with unresectable malignant pleural mesothelioma.
Non-small Cell Lung Cancer: Pemetrexed Kabi in combination with cisplatin is indicated for the first line treatment of patient with locally advanced or metastatic non-small cell lung cancer other than predominantly squamous cell histology.
Pemetrexed Kabi is indicated as monotherapy for the maintenance treatment of locally advanced or metastatic non-small cell lung cancer other than predominantly squamous cell histology in patients whose disease has not progressed immediately following platinum-based chemotherapy.
Pemetrexed Kabi is indicated as monotherapy for the second line treatment of patients with locally advanced or metastatic non-small cell lung cancer other than predominantly squamous cell histology.
